Suppr超能文献

人副流感病毒3型附着蛋白的神经氨酸酶活性对其激活融合蛋白能力的影响。

Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein.

作者信息

Porotto Matteo, Murrell Matthew, Greengard Olga, Doctor Lynne, Moscona Anne

机构信息

Department of Pediatrics, Mount Sinai School of Medicine, 1 Gustave L. Levy Pl., New York, NY 10029, USA.

出版信息

J Virol. 2005 Feb;79(4):2383-92. doi: 10.1128/JVI.79.4.2383-2392.2005.

Abstract

In order to examine functions of the hemagglutinin-neuraminidase (HN) protein that quantitatively influence fusion promotion, human parainfluenza virus 3 (HPIV3) variants with alterations in HN were studied. The variant HNs have mutations that affect either receptor binding avidity, neuraminidase activity, or fusion protein (F) activation. Neuraminidase activity was regulated by manipulation of temperature and pH. F activation was assessed by quantitating the irreversible binding of target erythrocytes (RBC) to HN/F-coexpressing cells in the presence of 4-GU-DANA (zanamivir) to release target cells bound only by HN-receptor interactions; the remaining, irreversibly bound target cells are retained via the fusion protein. In cells coexpressing wild-type (wt) or variant HNs with wt F, the fusion promotion capacity of HN was distinguished from target cell binding by measuring changes with time in the amounts of target RBC that were (i) reversibly bound by HN-receptor interaction (released only upon the addition of 4-GU-DANA), (ii) released by HN's neuraminidase, and (iii) irreversibly bound by F-insertion or fusion (F triggered). For wt HN, lowering the pH (to approach the optimum for HPIV3 neuraminidase) decreased F triggering via release of HN from its receptor. An HN variant with increased receptor binding avidity had F-triggering efficiency like that of wt HN at pH 8.0, but this efficiency was not decreased by lowering the pH to 5.7, which suggested that the variant HN's higher receptor binding activity counterbalanced the receptor dissociation promoted by increased neuraminidase activity. To dissect the specific contribution of neuraminidase to triggering, two variant HNs that are triggering-defective due to a mutation in the HN stalk were evaluated. One of these variants has, in addition, a mutation in the globular head that renders it neuraminidase dead, while the HN with the stalk mutation alone has 30% of wt neuraminidase. While the variant without neuraminidase activity triggered F effectively at 37 degrees C irrespective of pH, the variant possessing effective neuraminidase activity completely failed to activate F at pH 5.7 and was capable of only minimal triggering activity even at pH 8.0. These results demonstrate that neuraminidase activity impacts the extent of HPIV3-mediated fusion by releasing HN from contact with receptor. Any particular HN's competence to promote F-mediated fusion depends on the balance between its inherent F-triggering efficacy and its receptor-attachment regulatory functions (binding and receptor cleavage).

摘要

为了研究血凝素 - 神经氨酸酶(HN)蛋白在定量影响融合促进方面的功能,对HN发生改变的人副流感病毒3型(HPIV3)变体进行了研究。这些变体HN具有影响受体结合亲和力、神经氨酸酶活性或融合蛋白(F)激活的突变。通过调节温度和pH来调控神经氨酸酶活性。在存在4 - GU - DANA(扎那米韦)的情况下,通过定量靶红细胞(RBC)与共表达HN/F的细胞的不可逆结合来评估F激活,以释放仅通过HN - 受体相互作用结合的靶细胞;其余不可逆结合的靶细胞则通过融合蛋白得以保留。在共表达野生型(wt)或变体HN与wt F的细胞中,通过测量随时间变化的靶RBC数量来区分HN的融合促进能力与靶细胞结合情况,这些靶RBC分别为:(i)通过HN - 受体相互作用可逆结合(仅在添加4 - GU - DANA时释放);(ii)由HN的神经氨酸酶释放;(iii)通过F插入或融合不可逆结合(F触发)。对于wt HN,降低pH(接近HPIV3神经氨酸酶的最佳pH值)会通过使HN从其受体释放而降低F触发。一种受体结合亲和力增加的HN变体在pH 8.0时具有与wt HN相似的F触发效率,但将pH降至5.7时该效率并未降低,这表明变体HN较高的受体结合活性抵消了神经氨酸酶活性增加所促进的受体解离。为了剖析神经氨酸酶对触发的具体贡献,评估了两种由于HN柄部突变而触发缺陷的变体HN。其中一种变体在球状头部还有一个突变,使其神经氨酸酶失活,而仅具有柄部突变的HN具有wt神经氨酸酶活性的30%。虽然没有神经氨酸酶活性的变体在37℃时无论pH如何都能有效触发F,但具有有效神经氨酸酶活性的变体在pH 5.7时完全无法激活F,甚至在pH 8.0时也仅具有最小的触发活性。这些结果表明,神经氨酸酶活性通过使HN与受体脱离接触来影响HPIV3介导的融合程度。任何特定HN促进F介导融合的能力取决于其固有的F触发效力与其受体附着调节功能(结合和受体裂解)之间的平衡。

相似文献

引用本文的文献

1
How a paramyxovirus fusion/entry complex adapts to escape a neutralizing antibody.
Nat Commun. 2024 Oct 12;15(1):8831. doi: 10.1038/s41467-024-53082-y.
2
Human parainfluenza virus 3 field strains undergo extracellular fusion protein cleavage to activate entry.
mBio. 2024 Nov 13;15(11):e0232724. doi: 10.1128/mbio.02327-24. Epub 2024 Oct 9.
4
Unraveling dynamics of paramyxovirus-receptor interactions using nanoparticles displaying hemagglutinin-neuraminidase.
PLoS Pathog. 2024 Jul 25;20(7):e1012371. doi: 10.1371/journal.ppat.1012371. eCollection 2024 Jul.
5
Functional and structural basis of human parainfluenza virus type 3 neutralization with human monoclonal antibodies.
Nat Microbiol. 2024 Aug;9(8):2128-2143. doi: 10.1038/s41564-024-01722-w. Epub 2024 Jun 10.
6
Kinetic analysis of paramyxovirus-sialoglycan receptor interactions reveals virion motility.
PLoS Pathog. 2023 Mar 27;19(3):e1011273. doi: 10.1371/journal.ppat.1011273. eCollection 2023 Mar.
8
Parainfluenza virus entry at the onset of infection.
Adv Virus Res. 2021;111:1-29. doi: 10.1016/bs.aivir.2021.07.001. Epub 2021 Aug 23.
10
Inhibition of Measles Viral Fusion Is Enhanced by Targeting Multiple Domains of the Fusion Protein.
ACS Nano. 2021 Aug 24;15(8):12794-12803. doi: 10.1021/acsnano.1c02057. Epub 2021 Jul 22.

本文引用的文献

3
Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III.
J Mol Biol. 2004 Jan 30;335(5):1343-57. doi: 10.1016/j.jmb.2003.11.032.
4
A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion.
J Cell Biol. 2003 Oct 27;163(2):363-74. doi: 10.1083/jcb.200305130.
5
The release of influenza virus from the infected cell.
J Hyg (Lond). 1954 Jun;52(2):180-8. doi: 10.1017/s0022172400027388.
6
Structural features of paramyxovirus F protein required for fusion initiation.
Biochemistry. 2003 Jun 10;42(22):6645-55. doi: 10.1021/bi034385k.
8
Activation of fusion by the SER virus F protein: a low-pH-dependent paramyxovirus entry process.
J Virol. 2003 Jun;77(11):6520-7. doi: 10.1128/jvi.77.11.6520-6527.2003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验